What We're Reading: Page 317
Industry reads hand-picked by our editors
Jan 10, 2017
Jan 09, 2017
Jan 06, 2017
-
Bloomberg
Cheating death can cost $200,000 as cancer tops pharma sales
-
The Wall Street Journal
Teva gives downbeat earnings forecast
-
Forbes
Company will raise $1 billion to create blood test to detect cancer
-
Life Sci VC
Crystal ball gazing: biotech predictions for 2017
Jan 05, 2017
-
EP Vantage
Pharma stocks battered in 2016 storm
-
The Washington Post
Biden to tackle broad range of cancer issues, including drug prices, after leaving White House
-
The Wall Street Journal
Pennsylvania is ordered to provide hepatitis C drug to inmate
-
Boston Business Journal
Cambridge's Neon gets $70M infusion to develop 'bespoke cancer vaccine'
Jan 04, 2017
-
Forbes
30 under 30 in science 2017: Discovering new things about our world and new ways to save it
-
Bloomberg
Ono Pharma's wild 2016 ride cuts stock valuation by $16 billion
-
Health Affairs
Germany's model for drug price regulation could work in the US
-
The Boston Globe
Doctors are cutting opioids, even if it harms patients
-
Medical Marketing & Media
Pharma adopts data-science culture in move toward AI
Jan 03, 2017
-
Bloomberg
This army vet is fighting hep C with big pharma's help
-
The New York Times
National biotechnology panel faces new conflict of interest questions
-
BloombergGadfly
Biotech's back-to-the-future experiment
-
Reuters
Life-extending capacity of new cancer drugs varies widely
Jan 02, 2017
-
MIT Technology Review
Everything you need to know about gene therapy's most promising year
-
Bloomberg Gadfly
Brent Saunders's new model will be tested in 2017
-
Reuters
New drug approvals fall to six-year low in 2016
-
Forbes
Five 'big idea' biotech trends to watch in 2017
Previous
